Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZD4747 is a selective and potent inhibitor of the mutant GTPase KRASG12C that crosses the blood-brain barrier and has potential antitumor activity for the study of pancreatic and colorectal adenocarcinoma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 266.00 | |
5 mg | In stock | $ 652.00 | |
10 mg | In stock | $ 987.00 | |
25 mg | In stock | $ 2,180.00 | |
50 mg | In stock | $ 3,490.00 | |
100 mg | In stock | $ 5,620.00 |
Description | AZD4747 is a selective and potent inhibitor of the mutant GTPase KRASG12C that crosses the blood-brain barrier and has potential antitumor activity for the study of pancreatic and colorectal adenocarcinoma. |
Molecular Weight | 440.89 |
Formula | C24H22ClFN2O3 |
CAS No. | 2489226-14-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (226.81 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZD4747 2489226-14-2 GPCR/G Protein MAPK Ras inhibitor inhibit